Metis Pharma

IPO

剂泰科技(北京)股份有限公司

Metis Pharma was founded in 2019, is headquartered in Hangzhou, China, lists 51–200 employees, and has $150.0M in recorded funding across 1 round.

Headquarters
Hangzhou
Employees
51–200
Founded
2019
Business Model
B2B
Total Funding
$150.0M
Last Round
$150.0M Series BApr 2022
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

METiS Pharmaceuticals is an AI-driven innovative biotechnology company that harnesses targeted drug delivery technology to develop more effective drugs for patients. Through the integration of cutting-edge artificial intelligence with traditional pharmaceutical R&D, METiS accelerates the discovery and development of innovative drugs in a more efficient and precise manner, while leveraging its core technology platforms to support the broader pharmaceutical ecosystem. The company has developed the AiLNP platform for AI-designed nanoparticle drug delivery and has received FDA Orphan Drug designation for its hepatocellular carcinoma candidate.

Summary

Metis Pharma is an Artificial Intelligence company based in Hangzhou, China, founded in 2019. It lists 51–200 employees. It has raised $150.0M in total across 1 round, most recently a $150.0M Series B round in Apr 2022. Investors include PICC Capital Investment, China Life Equity and Sequoia China.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOMay 2026
$268.2M

Sign up to see all 2 events

Funding: Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026
xAI

xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

San Francisco, United States201–500Artificial Intelligence, Generative AI
Series ETotal funding$47.4BJan 2026
Waymo

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...

Mountain View, United States1001–5000Artificial Intelligence, Autonomous Vehicles
Venture RoundTotal funding$29.6BFeb 2026
Databricks

Databricks provides a unified data and AI platform that helps enterprises build and run applicati...

San Francisco, United States10001+Analytics, Artificial Intelligence
Series G+Total funding$20.0BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Metis Pharma on Indexed.vc
<a href="https://indexed.vc/companies/metis-pharma"><img src="https://indexed.vc/api/badge/company/metis-pharma" alt="Metis Pharma on Indexed.vc" width="260" height="76" /></a>